Finasteride and Musculoskeletal/Balance Symptoms
Based on the available evidence, finasteride is not established to cause muscle pain, joint pain, or equilibrium problems as recognized adverse effects. The FDA-approved drug label and major clinical guidelines do not list myalgia, arthralgia, or balance disturbances among finasteride's documented side effects 1.
What the Evidence Shows
Documented Adverse Effects
The established adverse effect profile of finasteride, based on extensive randomized controlled trials and guideline reviews, is limited to:
- Sexual dysfunction (decreased libido, erectile dysfunction, ejaculatory dysfunction)
- Gynecomastia
- Decreased ejaculate volume
These effects are well-documented in both the 2009 ASCO/AUA guidelines 2 and the 2021 AUA guideline 3, which synthesized data from 15 randomized controlled trials. The FDA label confirms these as the primary adverse events 1.
The Musculoskeletal Exception
Only one case report exists documenting finasteride-associated myalgia: A 2008 report described a 30-year-old man taking finasteride 5 mg daily for 10 years who developed diffuse muscle aches with markedly elevated creatine kinase (10,117 IU/L) 4. His symptoms resolved within 3 weeks of discontinuation. This represents an isolated case report—the lowest level of evidence—and has not been replicated in any controlled trials or pharmacovigilance databases.
No Evidence for Joint Pain or Balance Problems
- Arthralgia (joint pain): Not mentioned in any guideline, FDA label, or research evidence provided
- Equilibrium problems/balance disturbances: Not documented in any source
- Recent large-scale pharmacovigilance analyses (2025) examining 11,557 adverse event reports identified 73 different adverse events across 7 system organ classes 5, but musculoskeletal or vestibular symptoms were not among the significant signals
Clinical Implications
If Your Patient Reports These Symptoms
When a patient on finasteride presents with muscle pain, joint pain, or balance problems:
Do not automatically attribute these to finasteride based on current evidence
Pursue alternative diagnoses as you would for any patient with these complaints:
- Myalgia: Consider statin use, viral illness, autoimmune conditions, hypothyroidism
- Arthralgia: Evaluate for inflammatory arthritis, osteoarthritis, crystalline arthropathy
- Balance disturbances: Assess for vestibular disorders, neurological conditions, medication interactions
Consider a trial off finasteride if no other cause is identified and symptoms are severe, but recognize this is based on clinical judgment rather than established causation
Important Caveat
The "post-finasteride syndrome" (PFS) has been described as a controversial constellation of persistent symptoms after drug discontinuation 3. However, this syndrome primarily encompasses sexual, psychological, and cognitive symptoms—not musculoskeletal or vestibular complaints. The FDA added a warning about PFS based on anecdotal patient reports rather than prospective trial data, and the robustness of this evidence remains unclear 3.
What to Monitor Instead
Focus counseling and monitoring on the established adverse effects: